1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies

Editas Medicine Inc (EDIT) Files 10-K for the Fiscal Year Ended on December 31, 2017

March 08, 2018 | About:

Editas Medicine Inc (NASDAQ:EDIT) files its latest 10-K with SEC for the fiscal year ended on December 31, 2017. Editas Medicine Inc is a genome editing company which is engaged in treating patients with genetically defined diseases by correcting disease-causing genes. Editas Medicine Inc has a market cap of $1.94 billion; its shares were traded at around $42.81 with and P/S ratio of 157.40.

For the last quarter Editas Medicine Inc reported a revenue of $3.67 million, compared with the revenue of $0.90 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $13.7 million, an increase of 126.8% from last year.

The reported loss per diluted share was $2.98 for the year, compared with the loss per share of $0 in the previous year. The Editas Medicine Inc had an operating margin of -873.64%, compared with the operating margin of -1605.62% a year before. The 10-year historical median operating margin of Editas Medicine Inc is -1886.67%. The profitability rank of the company is 4 (out of 10).

At the current stock price of $42.81, Editas Medicine Inc is traded at 52.5% premium to its historical median P/S valuation band of $28.08. The P/S ratio of the stock is 157.40, while the historical median P/S ratio is 103.24. The stock gained 98.68% during the past 12 months.

CEO Recent Trades:

  • President and CEO Katrine Bosley sold 8,333 shares of EDIT stock on 03/01/2018 at the average price of $35.72. The price of the stock has increased by 19.85% since.

CFO Recent Trades:

  • CFO Andrew A. F. Hack sold 18,000 shares of EDIT stock on 02/16/2018 at the average price of $34.21. The price of the stock has increased by 25.14% since.

For the complete 20-year historical financial data of EDIT, click here.

Rating: 0.0/5 (0 votes)


Please leave your comment:

Performances of the stocks mentioned by insider

User Generated Screeners

louis16120031 Yr Momentum
flyflipperKW DCF 25+%
itflpalmsBRUCE Book
DBrizanall 2018Oct20 233a
DBrizanall 2018Oct20 1212a
meric99999Share Buyback
pbarker46Stock yield near hist. high
louis1612003SP600 ROC
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat